150 related articles for article (PubMed ID: 6763371)
1. Pharmacological and therapeutical experience with human interferon-beta in malignant tumors in children.
Niethammer D; Treuner J
Tex Rep Biol Med; 1981-1982; 41():641-6. PubMed ID: 6763371
[No Abstract] [Full Text] [Related]
2. Clinical investigation of partially pure and recombinant DNA derived leukocyte interferon in human cancer.
Gutterman J; Quesada J
Tex Rep Biol Med; 1981-1982; 41():626-33. PubMed ID: 6763369
[No Abstract] [Full Text] [Related]
3. [Recent findings in the field of oncological therapy with interferon].
Pugliese A; Vitale M; Cosseta P
G Batteriol Virol Immunol; 1981; 74(7-12):308-19. PubMed ID: 6182049
[No Abstract] [Full Text] [Related]
4. Interferons and cancer therapy.
Priestman TJ
J Pathol; 1983 Nov; 141(3):287-95. PubMed ID: 6363649
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent respiratory papillomatosis with interferon.
Sessions RB; Dichtel WJ; Goepfert H
Ear Nose Throat J; 1984 Oct; 63(10):488-93. PubMed ID: 6489206
[No Abstract] [Full Text] [Related]
6. [Interferon in the treatment of recurrent laryngeal papillomas].
Lenarcić-Cepelja I; Krajina Z
Laryngol Rhinol Otol (Stuttg); 1984 Aug; 63(8):401-2. PubMed ID: 6482620
[TBL] [Abstract][Full Text] [Related]
7. Studies with interferon-alpha in human tumors.
Einhorn S; Strander H
Med Oncol Tumor Pharmacother; 1984; 1(2):97-9. PubMed ID: 6400035
[TBL] [Abstract][Full Text] [Related]
8. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
Vacher S; Peytral C; Narcy P
Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
[TBL] [Abstract][Full Text] [Related]
9. Interferon joins attack on severe laryngeal papilloma.
White EC
JAMA; 1983 Oct; 250(14):1815. PubMed ID: 6620472
[No Abstract] [Full Text] [Related]
10. [Alpha-interferon treatment of juvenile laryngeal papillomatosis in adults].
Schuurman AM; van den Broek P
Ned Tijdschr Geneeskd; 1985 Dec; 129(52):2507-9. PubMed ID: 4088374
[No Abstract] [Full Text] [Related]
11. Recurrent respiratory papillomatosis.
Lancet; 1988 Dec; 2(8625):1406. PubMed ID: 2904531
[No Abstract] [Full Text] [Related]
12. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.
Zenner HP; Kley W; Clarós P; Clarós A; Labas Z; Löbe LP; Pavelka R; Plath P; Ribari O; Niethammer D
Oncology; 1985; 42 Suppl 1():15-8. PubMed ID: 3909032
[TBL] [Abstract][Full Text] [Related]
14. Three-year experience of treating recurrent respiratory papilloma with interferon.
Lusk RP; McCabe BF; Mixon JH
Ann Otol Rhinol Laryngol; 1987; 96(2 Pt 1):158-62. PubMed ID: 3551741
[TBL] [Abstract][Full Text] [Related]
15. Interferon as a biological response modifying agent in clinical trials.
Smalley RV; Oldham RK
J Biol Response Mod; 1983; 2(5):401-8. PubMed ID: 6358422
[No Abstract] [Full Text] [Related]
16. The clinical application of fibroblast interferon--an overview.
Billiau A
Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034
[TBL] [Abstract][Full Text] [Related]
17. [Attempt to produce antineoplastic immunity in children with laryngeal papillomatosis].
Il'in KV; Chireshkin DG; Spure ZhZh
Vestn Akad Med Nauk SSSR; 1971; 26(3):11-8. PubMed ID: 4931987
[No Abstract] [Full Text] [Related]
18. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
19. The regression of recurrent conjunctival papillomas by lymphoblastoid interferon treatment.
Chiemchaisri Y; Dongosintr N; Wasi C; Wanachiwanawin W; Tuchinda C; Yenchitsomanus T; Jaruthasana I
J Med Assoc Thai; 1990 Jul; 73(7):406-13. PubMed ID: 2246629
[No Abstract] [Full Text] [Related]
20. [Clinical trials of interferon-beta (MR-21) on malignant brain tumors].
Takakura K
Nihon Gan Chiryo Gakkai Shi; 1987 May; 22(4):801-8. PubMed ID: 3312440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
